Literature DB >> 22275489

Managing hyperglycaemia in patients with type 2 diabetes and known cardiovascular disease.

Tahseen A Chowdhury, Akhil Kapur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22275489      PMCID： PMC3265233          DOI： 10.1258/jrsm.2011.110162

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  11 in total

1.  Hyperglycaemia in acute coronary syndromes: summary of NICE guidance.

Authors:  A Senthinathan; V Kelly; M Dzingina; D Jones; M Baker; D Longson
Journal:  BMJ       Date:  2011-10-26

2.  Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Authors:  J S Yudkin; B Richter; E A M Gale
Journal:  Diabetologia       Date:  2010-08-05       Impact factor: 10.122

3.  Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

Authors:  K Malmberg; L Rydén; H Wedel; K Birkeland; A Bootsma; K Dickstein; S Efendic; M Fisher; A Hamsten; J Herlitz; P Hildebrandt; K MacLeod; M Laakso; C Torp-Pedersen; A Waldenström
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

4.  The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

Authors:  N Wah Cheung; Vincent W Wong; Mark McLean
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

5.  Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Authors:  Craig J Currie; John R Peters; Aodán Tynan; Marc Evans; Robert J Heine; Oswaldo L Bracco; Tony Zagar; Chris D Poole
Journal:  Lancet       Date:  2010-01-26       Impact factor: 79.321

6.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Authors:  Shamir R Mehta; Salim Yusuf; Rafael Díaz; Jun Zhu; Prem Pais; Denis Xavier; Ernesto Paolasso; Rashid Ahmed; Changchun Xie; Khawar Kazmi; Javed Tai; Andrés Orlandini; Janice Pogue; Lisheng Liu
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

7.  Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.

Authors:  S Akalin; K Berntorp; A Ceriello; A K Das; E S Kilpatrick; T Koblik; C S Munichoodappa; C Y Pan; W Rosenthall; M Shestakova; B Wolnik; V Woo; W Y Yang; M T Yilmaz
Journal:  Int J Clin Pract       Date:  2009-10       Impact factor: 2.503

8.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

9.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

Authors:  K Malmberg; L Rydén; S Efendic; J Herlitz; P Nicol; A Waldenström; H Wedel; L Welin
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

10.  Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Authors:  Ioanna Tzoulaki; Mariam Molokhia; Vasa Curcin; Mark P Little; Christopher J Millett; Anthea Ng; Robert I Hughes; Kamlesh Khunti; Martin R Wilkins; Azeem Majeed; Paul Elliott
Journal:  BMJ       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.